Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

74.75 1.80 −2.35%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
7 6 6 5

+8 more TTM periods

ROE
2.94% 3.71% 4.50% 4.82%
ROA
2.06% 2.62% 3.17% 3.38%
ROIC
2.38% 2.94% 3.38% 3.56%
Return on Tangible Assets
7.84% 9.78% 11.99% 13.02%
Average Days of Receivables
70.57 68.99 68.85 69.49
Free Cash Flow per Share
3.28 3.28 3.27 2.81
Free Cash Flow
1,594.00 1,596.00 1,613.00 1,385.00
Other line items

Show all line items

Columns are period end dates